Pharmacy and Therapeutics Committee Board members pictured: (front row) Karen Maltby, M.D., Louise Turman, Pharm.D., Wilma Wilbanks, R.Ph., Clyde Glenn, M.D., Geri Weiland, M.D., Deboarh Minor, Pharm.D.; (second row) Kim Rodgers, BS Pharm., R.Ph., Stanley Hartness, M.D., Spencer Sullivan, M.D., Brad Gilchrist, Pharm.D. (not pictured: Benjamin Brock, M.D. and Caleb Williamson, Pharm.D.)
The Mississippi Division of Medicaid’s Pharmacy and Therapeutics (P&T) Committee is comprised of twelve participating physicians, nurse practitioners, and practicing pharmacists who are active MS Medicaid providers and in good standing with their representative organizations. The P&T Committee is an advisory panel who conducts in-depth clinical evaluations and recommends appropriate drugs for preferred status on DOM’s Preferred Drug List (PDL) and/or drugs for prior authorization. Drugs and drug classes are evaluated for their safety, efficacy, and overall cost value and the committee will make subsequent recommendations to the Executive Director regarding prior authorization criteria for these drugs and classes.
The decision of the committee regarding any limitations to be imposed on any drug or its use for a specified indication shall be based on sound clinical evidence found in labeling, drug compendia, and peer reviewed clinical literature pertaining to use of the drug in the relevant population.
P&T Committee Meeting Information
The P&T Committee meets four (4) times annually. Meetings are held in room 145 of the Woolfolk Building located at 501 N. West Street, Jackson, MS 39201.
Registration is required for all pharmaceutical industry and advocacy representatives to be able to attend P&T Committee meetings. Registration opens 30 days prior to the meeting date and ends when registration limits have been reached or the day before the meeting. Only one (1) representative per company may register/attend.
Medicaid’s Pharmacy & Therapeutics Committee meeting schedule:
2023 P&T dates (tentative):
February 14, 2023- May 9, 2023
- August 8, 2023
- October 24, 2023
All meetings will be live with no virtual options.
P&T Committee Meeting Resources
NOTE: Registration is required for all pharmaceutical industry and advocacy representatives to be able to attend P&T Committee meetings.
- Industry, DOM Public Comment 2017
- P&T Committee Members
- Letter to Governmental Affairs Representatives
- Mississippi Pharmacy Program Frequently Asked Questions
- Link to PDL Change Provider Notice changes
P&T Committee Meeting Minutes and Agendas | Archive of Meeting Minutes and Agendas
| Date | P&T Meeting Minutes | Meeting Agenda |
|---|---|---|
| Feb. 14, 2023 | Minutes | Agenda |
| Oct. 18, 2022 | Minutes | Agenda |
| Aug. 9, 2022 | Minutes | Agenda |
| Feb. 15, 2022 | Minutes | Agenda |
Important Information for Drug Manufacturers
Change Healthcare (CHC), has been awarded the contract for Preferred Drug List Maintenance and Supplemental Rebate Program for the Mississippi Division of Medicaid (DOM) effective July 1, 2016.
Change Healthcare
P.O. Box 1090
Augusta, ME 04332-1090
Email: PBA_msrebate@changehealthcare.com
Industry Information Requests
Industry representatives with clinical inquires related to drugs listed on the Preferred Drug List may contact the Division’s clinical contractor, Change Healthcare (CHC). The primary contact at CHS for Mississippi Medicaid is:
Paige Clayton, Pharm.D.
Email: pclayton@changehealthcare.com
P&T Committee Contacts
Please route inquiries regarding the P&T Committee to the Bureau of Pharmacy to the following.
Phone: (601) 359-5253
Email: DOMPharmacyOffice@medicaid.ms.gov
